📊 Score Breakdown
Offering Ability
100
Cash Runway
95
Float Risk
80
Warrant Exposure
90
Convertible Debt—
🌦️ Dilution Forecast
🌩️
Severe
Multiple high-probability dilution events detected
67%
💰 Capital Raise
93%
• Critical: only 1.7 months cash remaining
• Active shelf registration ($75M, 1868% of market cap)
📜 Warrant Exercise
60%
• Massive warrant overhang: 464% of shares outstanding
• Warrant risk score very high (90/100)
🔄 Reverse Split
15%
• Only 2 months cash — financial pressure
💹 Market Data
Market Cap$4.02M
Shares Outstanding2.18M
Float644.7K
Cash$600.0K
Debt$678.0K
Short InterestN/A
🏛 Institutional Holdings
8 institutional holders · 32.8K shares
#1
UBS Group AG
11.2K shares
#2
Two Sigma Investments, LP
6.9K shares
#3
Virtu Financial LLC
5.6K shares
+ 5 more holders Sign up free to view →
📉 Short Interest
Short Interest62.5K
Days to Cover1.0
% of Float9.7%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Mar 31, 2026
xbrl
XBRL WARRANT
Mar 31, 2026
S-3
SHELF
May 04, 2026
424B3
ATM
Apr 16, 2026
EFFECT
EFFECT
Apr 15, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ARTL
📊 ARTL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ARTL Signal Convergence & Dark Pool Activity — StonkWhisper
📄 ARTL Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.